CHPT1
Basic information
Region (hg38): 12:101696947-101744140
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHPT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 12 | |||||
Total | 0 | 0 | 22 | 1 | 6 |
Variants in CHPT1
This is a list of pathogenic ClinVar variants found in the CHPT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-101697886-T-G | not specified | Uncertain significance (Aug 08, 2022) | ||
12-101697908-C-A | not specified | Uncertain significance (May 26, 2024) | ||
12-101697937-C-G | not specified | Uncertain significance (Dec 09, 2023) | ||
12-101697952-G-C | not specified | Uncertain significance (Mar 28, 2022) | ||
12-101697988-G-C | not specified | Uncertain significance (Oct 13, 2023) | ||
12-101698118-C-G | not specified | Uncertain significance (Apr 24, 2023) | ||
12-101714097-A-G | not specified | Uncertain significance (Dec 03, 2021) | ||
12-101714234-A-G | not specified | Uncertain significance (May 30, 2023) | ||
12-101716732-G-T | not specified | Uncertain significance (Mar 25, 2024) | ||
12-101716735-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
12-101716792-G-C | not specified | Uncertain significance (May 27, 2022) | ||
12-101716793-C-T | not specified | Uncertain significance (Jul 21, 2022) | ||
12-101720150-A-T | not specified | Uncertain significance (Jul 20, 2021) | ||
12-101720156-C-G | not specified | Uncertain significance (Dec 14, 2022) | ||
12-101723182-G-T | not specified | Uncertain significance (May 30, 2023) | ||
12-101723803-T-C | Benign (Jun 22, 2018) | |||
12-101726326-T-G | not specified | Uncertain significance (Nov 09, 2023) | ||
12-101726327-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
12-101726357-C-G | not specified | Uncertain significance (Mar 16, 2024) | ||
12-101726374-C-T | Benign (Jun 11, 2018) | |||
12-101728682-TAGAG-T | Spermatogenic Failure | Likely benign (Jun 14, 2016) | ||
12-101728684-G-C | Spermatogenic failure 4 | Uncertain significance (Jan 12, 2018) | ||
12-101728722-C-T | Spermatogenic failure 4 | Benign (Jan 12, 2018) | ||
12-101728729-C-T | Spermatogenic failure 4 | Uncertain significance (Jan 13, 2018) | ||
12-101728744-T-C | Spermatogenic failure 4 | Benign (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHPT1 | protein_coding | protein_coding | ENST00000229266 | 9 | 47194 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000243 | 0.984 | 125720 | 0 | 22 | 125742 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.823 | 161 | 193 | 0.833 | 0.00000868 | 2582 |
Missense in Polyphen | 65 | 69.91 | 0.92977 | 920 | ||
Synonymous | 0.0911 | 71 | 72.0 | 0.986 | 0.00000339 | 795 |
Loss of Function | 2.13 | 9 | 19.0 | 0.473 | 8.03e-7 | 253 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000160 | 0.000157 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000830 | 0.0000791 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000269 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes phosphatidylcholine biosynthesis from CDP- choline. It thereby plays a central role in the formation and maintenance of vesicular membranes.;
- Pathway
- Ether lipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Phosphonate and phosphinate metabolism - Homo sapiens (human);Lamivudine Pathway, Pharmacokinetics/Pharmacodynamics;Lamivudine Metabolism Pathway;Phospholipid Biosynthesis;Kennedy pathway from Sphingolipids;One carbon metabolism and related pathways;Metabolism of lipids;phosphatidylcholine biosynthesis;Metabolism;Synthesis of PC;Glycerophospholipid metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0901
Intolerance Scores
- loftool
- 0.648
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Haploinsufficiency Scores
- pHI
- 0.0824
- hipred
- N
- hipred_score
- 0.450
- ghis
- 0.414
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.168
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chpt1
- Phenotype
Gene ontology
- Biological process
- regulation of cell growth;lipid metabolic process;phosphatidylcholine biosynthetic process;CDP-choline pathway;platelet activating factor biosynthetic process
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;Golgi apparatus;membrane;integral component of membrane;intracellular membrane-bounded organelle
- Molecular function
- diacylglycerol cholinephosphotransferase activity;phosphotransferase activity, for other substituted phosphate groups;diacylglycerol binding;metal ion binding